跳至主要内容
临床试验/NCT05867407
NCT05867407
终止
不适用

A Prospective Pragmatic Cluster-Randomized Care-as-Usual Controlled Study to Evaluate the Impact of an ECG-Based AI Algorithm to Detect Low Left Ventricular Ejection Fraction on Diagnosis Rates of LVEF ≤40% in the Outpatient Setting

Anumana, Inc.5 个研究点 分布在 1 个国家目标入组 11,610 人2024年6月13日

概览

阶段
不适用
干预措施
未指定
疾病 / 适应症
Ventricular Ejection Fraction
发起方
Anumana, Inc.
入组人数
11610
试验地点
5
主要终点
Diagnosis rates of low ejection fraction of less than or equal to 40 percent by echocardiography compared to care-as-usual
状态
终止
最后更新
8个月前

概览

简要总结

A prospective, cluster-randomized, care-as-usual controlled trial to evaluate the impact of an ECG-based artificial intelligence (ECG-AI) algorithm to detect low left ventricular ejection fraction (LVEF) on diagnosis rates of LVEF ≤ 40% in the outpatient setting.

The objective of this study is to evaluate the impacts of an ECG-AI algorithm to detect low LVEF and an associated Medical Device Data System when used during routine outpatient care. The study will be conducted in 2 phases: feasibility assessment phase and clinical impact phase.

详细描述

The study is a prospective, cluster randomized, care-as-usual controlled trial that will be conducted at 6 sites in the USA. Primary care clinicians and general cardiologists will be invited and consented to participate in the study. For clinicians that accept, practice groups will be randomized to receive access to and education about the Low EF AI-ECG software and encompassing software or to provide care-as-usual in the control group. The study will be conducted in two phases: a feasibility pilot to evaluate integration and usability followed by observational period(s) to evaluate clinical outcomes. Analyses of the primary and secondary endpoints will be conducted on data from patients that meet the inclusion and exclusion criteria. The expected duration of the study is 12 months, including a feasibility phase (estimated 6 weeks) followed by a 3-month initial observation period with rolling observation count monitoring until the target number of patient encounters is reached, followed by a 90-day follow up period. At the completion of the feasibility period, we will evaluate quantitative and qualitative outcomes to inform the following observational period(s). Primary endpoints and exploratory endpoints will be assessed the end of the study.

注册库
clinicaltrials.gov
开始日期
2024年6月13日
结束日期
2025年5月30日
最后更新
8个月前
研究类型
Interventional
研究设计
Parallel
性别
All

研究者

发起方
Anumana, Inc.
责任方
Sponsor

入排标准

入选标准

  • Males and females 18 years or older (including females who are pregnant, breastfeeding and/or lactating)
  • Digital ECG captured or available within site for ECG-AI analysis at point-of-care

排除标准

  • Known history of LVEF ≤ 40%
  • Known history of systolic heart failure
  • Known history of heart failure with reduced ejection fraction
  • Opted out of electronic health record-based research

结局指标

主要结局

Diagnosis rates of low ejection fraction of less than or equal to 40 percent by echocardiography compared to care-as-usual

时间窗: 90 days

Diagnosis rates of low ejection fraction of less than or equal to 40 percent by echocardiography compared to care-as-usual

研究点 (5)

Loading locations...

相似试验